title: [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
authors.affiliation: Multiple Sclerosis Center, NHO Utano National Hospital, Japan.
authors.forename: Masami
authors.initials: M
authors.lastname: Tanaka
authors.forename: Keiko
authors.initials: K
authors.lastname: Tanaka
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D000068876:Fingolimod Hydrochloride; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D009471:Neuromyelitis Optica / Q000175:diagnosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use; D055502:Secondary Prevention; D013110:Sphingosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine